Merja Haaparanta-Solin
Adj.prof.
MediCity Research Laboratories, PET merja.haaparanta-solin@utu.fi +358 40 715 1742 Tykistökatu 6 Turku |
- F-18-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease (2016)
- European Journal of Pharmaceutical SciencesJournal of Labelled Compounds and Radiopharmaceuticals
- HPLC and TLC methods for analysis of [F-18]flumazenil and its metabolites from biological samples (2016)
- European Journal of Nuclear Medicine and Molecular ImagingDiabetologia
- Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese (2016)
- Brain Research
- (2016)
- Journal of Nuclear Medicine
- Amphetamine Decreases α2C-Adrenoceptor Binding of [11C]ORM-13070 - A PET Study in the Primate Brain (2015)
- International Journal of NeuropsychopharmacologyJournal of Nuclear Medicine
- Anti-VLA-4 treatment reduces microglial activation in a focal EAE-model (2015)
- GliaJournal of Nuclear Medicine
- Electrophilic fluorination and preclinical evaluation of a novel [F-18]DPA-714 analogue, [F-18]F-DPA (2015)
- Enhanced fatty acid uptake in visceral adipose tissue is not reversed by weight loss in obese individuals with the metabolic syndrome (2015)
- Imaging mitochondrial membrane potential using a novel F-18-labeled BMS derivative (F-18-FP10X) (2015)
- In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis (2015)



